Canopy Growth (CGC) Change in Accured Expenses (2019 - 2026)
Canopy Growth (CGC) posted Change in Accured Expenses of -$1.6 million for Q4 2025, down 141.74% sequentially from $3.7 million in Q2 2025, and down 143.64% YoY from $3.6 million in Q4 2024.
Canopy Growth (CGC) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Canopy Growth has reported Change in Accured Expenses for 7 years, with the latest figure at -$1.6 million in Q4 2025.
- Quarterly Change in Accured Expenses fell 143.64% year-over-year to -$1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.0 million (up 6.19% YoY) and the FY2026 annual result came in at -$3.2 million, up 70.58% from the prior year.
- Change in Accured Expenses slipped to -$1.6 million in Q4 2025 per CGC's latest filing, from $3.7 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $10.7 million in Q3 2021 and troughed at -$27.4 million in Q4 2021.
- A 5-year average of -$3.2 million and a median of -$2.9 million in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses soared 983.78% in 2021, then sank 453.49% in 2022.
- Over 5 years, Change in Accured Expenses stood at -$27.4 million in 2021, then jumped by 84.85% to -$4.2 million in 2022, then soared by 346.37% to $10.2 million in 2023, then sank by 65.02% to $3.6 million in 2024, then slumped by 143.64% to -$1.6 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.6 million, $3.7 million, and $3.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | -1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.75 Mn |
| Jun 30, 2026 | -1.75 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | -11.79 Mn |
| Sep 30, 2024 | -11.79 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Jun 30, 2024 | -4.32 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | -13.41 Mn |
| Jun 30, 2023 | -13.41 Mn |